INOCARDIA
Inocardia is a Coventry University spinout focused on the provision of Contract Research Services via the development of assays targeted at the biotech and pharmaceutical sectors. Inocardia has developed the โwork-loopโ model as a pre-clinical myocardial assay assessing cardiac contractility in normal, diseased and ageing myocardium in order to determine the cardiovascular safety of lead pharmaceutical compounds. The Coventry University work-loop assay is the only relevant in-vitro human model of cardio-toxicity available worldwide. Both the pharmaceutical industry and regulators recognise that contractility assessment is currently fraught with problems.
INOCARDIA
Industry:
Biopharma Biotechnology Life Science
Founded:
2013-01-01
Address:
Coventry, Coventry, United Kingdom
Country:
United Kingdom
Website Url:
http://www.inocardia.co.uk
Total Employee:
1+
Status:
Active
Contact:
+44 (0)7988 563489
Email Addresses:
[email protected]
Total Funding:
229 K GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Content Delivery Network Nginx Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS
Similar Organizations
LNC Therapeutics
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases.
Tierra Biosciences, Inc.
Speed, scale and simplicity with protein on-demand
Current Employees Featured
Founder
Investors List
Mercia Fund Managers
Mercia Fund Managers investment in Venture Round - InoCardia
Official Site Inspections
http://www.inocardia.co.uk
- Host name: www.fastlaneswimming.us
- IP address: 69.163.136.50
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821